Connective Tissue Growth Factor (CTGF) Expression Modulates Response to High Glucose

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  James, Leighton R ^a,b   Le, Catherine ^b   Doherty, Heather ^c   Kim, Hyung Suk ^c   Maeda, Nobuyo ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; COLLAGEN TYPE 1; COLLAGEN TYPE 13; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; FIBRONECTIN; GLUCOSE; NEPHRIN; SCLEROPROTEIN; STREPTOZOCIN; THROMBOSPONDIN 1; TRIACYLGLYCEROL;

ADRENAL CORTEX; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL EXPANSION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CTGF GENE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; EMBRYO; FIBROBLAST; GENE; GENE ACTIVATION; GENE EXPRESSION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HETEROZYGOSITY; HOMOZYGOSITY; KIDNEY FUNCTION; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; CONNECTIVE TISSUE GROWTH FACTOR; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GENE ORDER; GENE TARGETING; GENOTYPE; GLOMERULAR MESANGIUM; GLUCOSE; KIDNEY; MALE; MICE; MICE, KNOCKOUT; PROTEINURIA; RNA, MESSENGER;

EID: 84881494335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070441     Document Type: Article

References (64)

1. Brigstock DR, (2003) The CCN family: a new stimulus package. J Endocrinol 178: 169-175.
2. Perbal B, (2001) The CCN family of genes: a brief history. Mol Pathol 54: 103-104.
3. Perbal B, (2004) CCN proteins: multifunctional signalling regulators. Lancet 363: 62-64.
4. Rachfal AW, Brigstock DR, (2005) Structural and functional properties of CCN proteins. Vitam Horm 70: 69-103.
5. Brigstock D, Lau L, Perbal B, (2005) Report and abstracts of the 3rd International Workshop on the CCN Family of Genes. St Malo, France, 20-23 October 2004. J Clin Pathol 58: 463-478.
6. Liu X, Luo F, Pan K, Wu W, Chen H, (2007) High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells. BMC Cell Biol 8: 1.
7. Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, et al. (2008) Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. J Diabetes Complications 22: 284-294.
8. Sonnylal S, Shi-wen X, Leoni P, Naff K, Van PC, et al. (2010) Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 10.1002/art.27382 [doi].
9. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, et al. (2007) A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 357: 1210-1220.
10. Granel B, Argiro L, Hachulla E, Fajardy I, Weiller PJ, et al. (2010) Association between a CTGF gene polymorphism and systemic sclerosis in a French population. J Rheumatol 37: 351-358 jrheum.090290 [pii]; 10.3899/jrheum.090290 [doi].
11. Kawaguchi Y, Ota Y, Kawamoto M, Ito I, Tsuchiya N, et al. (2009) Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis 68: 1921-1924 ard.2008.100586 [pii]; 10.1136/ard.2008.100586 [doi].
12. Dessein A, Chevillard C, Arnaud V, Hou X, Hamdoun AA, et al. (2009) Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes. J Exp Med 206: 2321-2328 jem.20090383 [pii]; 10.1084/jem.20090383 [doi].
13. Gourh P, Mayes MD, Arnett FC, (2008) CTGF polymorphism associated with systemic sclerosis. N Engl J Med 358: 308-309.
14. Rueda B, Simeon C, Hesselstrand R, Herrick A, Worthington J, et al. (2009) A large multicentre analysis of CTGF-945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis 68: 1618-1620 ard.2008.100180 [pii]; 10.1136/ard.2008.100180 [doi].
15. Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, et al. (2009) Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat 16: 612-620 JVH1110 [pii]; 10.1111/j.1365-2893.2009.01110.x [doi].
16. Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, et al. (2005) Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy. Kidney Int 67: 2325-2329.
17. Nguyen TQ, Tarnow L, Andersen S, Hovind P, Parving HH, et al. (2006) Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 29: 83-88.
18. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, et al. (2005) Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 48: 2650-2660.
19. Roestenberg P, van Nieuwenhoven FA, Joles JA, Trischberger C, Martens PP, et al. (2005) Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol.
20. Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, Bovenschen N, Li Z, et al. (2008) CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy. J Am Soc Nephrol.
21. Caron KM, James LR, Kim HS, Morham SG, Lopez MSS, et al. (2002) A targeted renin transgene causes reversible hypertension and kidney damage in mice. Hypertension 40: 384.
22. Kunjathoor VV, Wilson DL, LeBoeuf RC, (1996) Increased atherosclerosis in Streptozotocin-induced diabetic mice. Journal of Clinical Investigation 97: 1767-1773.
23. Clark EA, Fanguy JC, Henry CS, (2001) High-throughput multi-analyte screening for renal disease using capillary electrophoresis. J Pharm Biomed Anal 25: 795-801.
24. Zinellu A, Caria MA, Tavera C, Sotgia S, Chessa R, et al. (2005) Plasma creatinine and creatine quantification by capillary electrophoresis diode array detector. Anal Biochem 342: 186-193.
25. Yi X, Nickeleit V, James LR, Maeda N, (2011) alpha-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy. J Diabetes Complications 25: 193-201 S1056-8727(10)00075-9 [pii]; 10.1016/j.jdiacomp.2010.07.004 [doi].
26. Tolstonog GV, Shoeman RL, Traub U, Traub P, (2001) Role of the intermediate filament protein vimentin in delaying senescence and in the spontaneous immortalization of mouse embryo fibroblasts. DNA Cell Biol 20: 509-529.
27. Tolstonog GV, Belichenko-Weitzmann IV, Lu JP, Hartig R, Shoeman RL, et al. (2005) Spontaneously immortalized mouse embryo fibroblasts: growth behavior of wild-type and vimentin-deficient cells in relation to mitochondrial structure and activity. DNA Cell Biol 24: 680-709.
28. Barcelli U, Rademacher R, Ooi YM, Ooi BS, (1981) Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system. J Clin Invest 67: 20-27.
29. MacCarthy EP, Hsu A, Ooi YM, Ooi BS, (1985) Evidence for a mouse mesangial cell-derived factor that stimulates lymphocyte proliferation. J Clin Invest 76: 426-430.
30. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 162: 156-159.
31. James LR, Ingram A, Ly H, Thai K, Cai L, et al. (2001) Angiotensin II activates the GFAT promoter in mesangial cells. Am J Physiol Renal Physiol 281: F151-F162.
32. Shastry S, Tyagi SC, (2004) Homocysteine induces metalloproteinase and shedding of beta-1 integrin in microvessel endothelial cells. J Cell Biochem 93: 207-213.
33. Kim HS, Lee G, John SWM, Maeda N, Smithies O, (2002) Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration. Proceedings of the National Academy of Sciences of the United States of America 99: 4602-4607.
34. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, et al. (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130: 2779-2791.
35. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R, (2007) Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 21: 3355-3368.
36. Barnes JL, Gorin Y, (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 79: 944-956 ki2010516 [pii]; 10.1038/ki.2010.516 [doi].
37. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R, (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287 ASN.2008050513 [pii]; 10.1681/ASN.2008050513 [doi].
38. Wang S, Skorczewski J, Feng X, Mei L, Murphy-Ullrich JE, (2004) Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2. J Biol Chem 279: 34311-34322.
39. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, et al. (2004) Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" BALB/c mouse lungs. Am J Respir Cell Mol Biol 31: 510-516.
40. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, et al. (1999) Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 13: 1774-1786.
41. Lam S, van der Geest RN, Verhagen NA, van Nieuwenhoven FA, Blom IE, et al. (2003) Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 52: 2975-2983.
42. Gomez-Garre D, Martin-Ventura JL, Granados R, Sancho T, Torres R, et al. (2006) Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. Kidney Int 69: 1237-1244 5000034 [pii]; 10.1038/sj.ki.5000034 [doi].
43. Bernardi S, Candido R, Toffoli B, Carretta R, Fabris B, (2011) Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. Nephrol Dial Transplant 26: 832-838 gfq524 [pii]; 10.1093/ndt/gfq524 [doi].
44. Gurley SB, Mach CL, Stegbauer J, Yang J, Snow KP, et al. (2010) Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol 298: F788-F795 90515.2008 [pii]; 10.1152/ajprenal.90515.2008 [doi].
45. Kreisberg RA, (1998) Diabetic dyslipidemia. Am J Cardiol 82: 67U-73U.
46. James L, Bhuiyan AK, Foster D, Seccombe D, (1995) Effect of L-carnitine treatment on very low density lipoprotein kinetics in the hyperlipidemic rabbit. Clin Biochem 28: 451-458 0009912095000266 [pii].
47. Blackberg L, Hernell O, Olivecrona T, (1981) Hydrolysis of human milk fat globules by pancreatic lipase: role of colipase, phospholipase A2, and bile salts. J Clin Invest 67: 1748-1752.
48. Reitsma JB, Castro CM, de Bruin TW, Erkelens DW, (1994) Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor. Metabolism 43: 293-298.
49. Guney MA, Petersen CP, Boustani A, Duncan MR, Gunasekaran U, et al. (2011) Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells. Proc Natl Acad Sci U S A 108: 15242-15247 1100072108 [pii]; 10.1073/pnas.1100072108 [doi].
50. Jacobson A, Cunningham JL, (2012) Connective tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue Repair 5 Suppl 1: S8 1755-1536-5-S1-S8 [pii]; 10.1186/1755-1536-5-S1-S8 [doi].
51. Brosius FC III, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, et al. (2009) Mouse models of diabetic nephropathy. J Am Soc Nephrol 20: 2503-2512 ASN.2009070721 [pii]; 10.1681/ASN.2009070721 [doi].
52. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285.
53. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, et al. (2001) Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 276: 15240-15248.
54. Seppinen L, Pihlajaniemi T, (2011) The multiple functions of collagen XVIII in development and disease. Matrix Biol 30: 83-92 S0945-053X(10)00177-0 [pii]; 10.1016/j.matbio.2010.11.001 [doi].
55. Hamano Y, Okude T, Shirai R, Sato I, Kimura R, et al. (2010) Lack of collagen XVIII/endostatin exacerbates immune-mediated glomerulonephritis. J Am Soc Nephrol 21: 1445-1455 ASN.2009050492 [pii]; 10.1681/ASN.2009050492 [doi].
56. Kinnunen AI, Sormunen R, Elamaa H, Seppinen L, Miller RT, et al. (2011) Lack of collagen XVIII long isoforms affects kidney podocytes, whereas the short form is needed in the proximal tubular basement membrane. J Biol Chem 286: 7755-7764 M110.166132 [pii]; 10.1074/jbc.M110.166132 [doi].
57. Falke LL, Dendooven A, Leeuwis JW, Nguyen TQ, van Geest RJ, et al. (2012) Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney. Matrix Biol 31: 421-431 S0945-053X(12)00087-X [pii]; 10.1016/j.matbio.2012.06.002 [doi].
58. Wang S, deNichilo M, Brubaker C, Hirschberg R, (2001) Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60: 96-105.
59. Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE, (2000) Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 157: 1353-1363 S0002-9440(10)64649-4 [pii].
60. Turk T, Leeuwis JW, Gray J, Torti SV, Lyons KM, et al. (2009) BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J Histochem Cytochem 57: 623-631 jhc.2009.953224 [pii]; 10.1369/jhc.2009.953224 [doi].
61. Wang B, Carter RE, Jaffa MA, Nakerakanti S, Lackland D, et al. (2010) Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet 47: 391-397 47/6/391 [pii]; 10.1136/jmg.2009.073098 [doi].
62. Cozzolino M, Biondi ML, Banfi E, Riser BL, Mehmeti F, et al. (2010) CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients. Blood Purif 30: 272-276 000320706 [pii]; 10.1159/000320706 [doi].
63. Patel SK, Wai B, Macisaac RJ, Grant S, Velkoska E, et al. (2012) The CTGF gene-945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes. Cardiovasc Diabetol 11: 42 1475-2840-11-42 [pii]; 10.1186/1475-2840-11-42 [doi].
64. Dendooven A, Nguyen TQ, Brosens L, Li D, Tarnow L, et al. (2011) The CTGF-945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes. J Negat Results Biomed 10: 4 1477-5751-10-4 [pii]; 10.1186/1477-5751-10-4 [doi].